736 related articles for article (PubMed ID: 36429042)
1. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
3. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
4. [CRISPR/Cas9 technology in disease research and therapy: a review].
Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
[TBL] [Abstract][Full Text] [Related]
5. Basics of genome editing technology and its application in livestock species.
Petersen B
Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
7. Genome editing in cardiovascular diseases.
Mani I
Prog Mol Biol Transl Sci; 2021; 181():289-308. PubMed ID: 34127197
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
9. Gene editing and CRISPR in the clinic: current and future perspectives.
Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
[TBL] [Abstract][Full Text] [Related]
10. Construction and Evaluation of Zinc Finger Nucleases.
Ochiai H; Yamamoto T
Methods Mol Biol; 2023; 2637():1-25. PubMed ID: 36773134
[TBL] [Abstract][Full Text] [Related]
11. [Application of CRISPR-Cas9 gene editing technology in crop breeding].
Yin W; Chen Z; Huang J; Ye H; Lu T; Lu M; Rao Y
Sheng Wu Gong Cheng Xue Bao; 2023 Feb; 39(2):399-424. PubMed ID: 36847080
[TBL] [Abstract][Full Text] [Related]
12. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.
Okoli A; Okeke MI; Tryland M; Moens U
Viruses; 2018 Jan; 10(1):. PubMed ID: 29361752
[TBL] [Abstract][Full Text] [Related]
14. A beginner's guide to gene editing.
Harrison PT; Hart S
Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
[TBL] [Abstract][Full Text] [Related]
15. Genome editing in plants: Advancing crop transformation and overview of tools.
Shah T; Andleeb T; Lateef S; Noor MA
Plant Physiol Biochem; 2018 Oct; 131():12-21. PubMed ID: 29754773
[TBL] [Abstract][Full Text] [Related]
16. Application of CRISPR-Cas systems in neuroscience.
Bonnerjee D; Bagh S
Prog Mol Biol Transl Sci; 2021; 178():231-264. PubMed ID: 33685599
[TBL] [Abstract][Full Text] [Related]
17. The era of editing plant genomes using CRISPR/Cas: A critical appraisal.
Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT
J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Delivery Systems for Therapeutic Genome Editing.
Wang L; Li F; Dang L; Liang C; Wang C; He B; Liu J; Li D; Wu X; Xu X; Lu A; Zhang G
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128905
[TBL] [Abstract][Full Text] [Related]
19. Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals.
Wani AK; Akhtar N; Singh R; Prakash A; Raza SHA; Cavalu S; Chopra C; Madkour M; Elolimy A; Hashem NM
Vet Res Commun; 2023 Jan; 47(1):1-16. PubMed ID: 35781172
[TBL] [Abstract][Full Text] [Related]
20. Concerns regarding 'off-target' activity of genome editing endonucleases.
Kadam US; Shelake RM; Chavhan RL; Suprasanna P
Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
